Last update:
Medications news
Expert argues psychedelics too unruly for traditional product development
Investor appetite in corporate psychedelia is returning, but the sector faces fundamental barriers to profitability, according to new research.
5 hours ago
0
0
Chemotherapy drug for brain cancer may be more effective at certain times of the day
When doctors biopsy and treat cancer may be just as important as how they treat it. New research from Erik Herzog, Ph.D., the Viktor Hamburger Distinguished Professor in biology in Arts & Sciences at Washington University ...
10 hours ago
0
0
FDA's plan to boost biosimilar drugs could stall at the patent office
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the cheaper medicines to get ...
16 hours ago
0
0
New cholesterol-lowering pill reduces bad cholesterol levels by almost 60%
Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial hypercholesterolemia (HeFH), a genetic disorder that leads to high levels of LDL cholesterol.
Zalunfiban shows early benefits in ST-elevation heart attacks
Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug zalunfiban given at first medical contact for suspected ST-elevation myocardial infarction (STEMI) improved ...
Targeted drug could benefit young patients with invasive sarcoma
A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at the University of Utah, has identified a targeted drug that could effectively treat an aggressive ...
Nov 19, 2025
0
0
Study sheds light on cellular resistance to osimertinib in adenocarcinoma
Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now discovered a molecular-level resistance mechanism that begins to take hold as early as six to eight ...
Nov 19, 2025
0
0
Novo Nordisk rolls out lower prices for Ozempic and Wegovy
People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.
Nov 19, 2025
0
0
Shingles vaccine most promising common drug to potentially prevent Alzheimer's
A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.
Nov 18, 2025
0
35
Tackling chemotherapy resistance in throat cancer—a potential new pathway
A University of Sheffield researcher has uncovered new evidence that could help improve treatment options for patients with hard-to-treat throat cancer.
Nov 18, 2025
0
0
Molecule: What's in this dangerous, illegal slimming pill?
It's the kind of promise that stops thumbs mid-scroll: "Take Molecule and forget food exists." Viral TikTok clips show influencers flaunting rapid weight-loss transformations, tapping into the body image concerns that leave ...
Nov 18, 2025
0
0
How does the hair-loss drug finasteride work? Can it affect my mental health?
For many men, the gradual thinning of hair is about more than just their appearance. Finasteride, a drug widely prescribed for the treatment of male pattern baldness, has been used effectively for many years for this deeply ...
Nov 18, 2025
0
0
New malaria drug heralds resistance breakthrough
The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis announced it was as effective at treating the disease as established treatments.
Nov 18, 2025
0
0
Understanding and preventing antimicrobial resistance
Antimicrobial Awareness Week, Nov. 18–24, serves as a global call to action to address antimicrobial resistance (AMR)—a growing public health concern that occurs when bacteria, viruses, fungi and parasites stop responding ...
Nov 18, 2025
0
0
Medications change our gut microbiome in predictable ways, research reveals
Our gut microbiome is made up of trillions of bacteria and other microbes living in our intestines. These help our bodies break down food, assist our immune system, send chemical signals to our brain, and potentially serve ...
Nov 17, 2025
0
60
Tirzepatide may only temporarily suppress brain 'food noise' activity
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the brain's "reward center" ...
Nov 17, 2025
0
10
How a new drug kills sleeping sickness parasites by damaging their DNA
Trypanosomatids are parasites that can result in more than 1 billion potentially fatal infections per year globally. In Africa, Human African Trypanosomiasis (HAT), better known as sleeping sickness, causes a devastating ...
Nov 17, 2025
0
0
Researchers study omega-3 fatty acids as a way to prevent preterm birth
SAHMRI's long-term research into omega-3 fatty acids as a way to prevent preterm birth is set to improve antenatal care across the globe.
Nov 17, 2025
0
0
One of the world's oldest blood pressure drugs may also halt aggressive brain tumor growth
A Penn-led team has revealed how hydralazine, one of the world's oldest blood pressure drugs and a mainstay treatment for preeclampsia, works at the molecular level. In doing so, they made a surprising discovery—it can ...
Nov 16, 2025
0
253
US narrows use of muscle-wasting therapy after teen deaths
The United States on Friday said it would add its most serious warning label to a gene therapy treatment for a debilitating muscle-wasting disease, and also limit its approved use.
Nov 15, 2025
0
0
When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show
In season three of the hit television series "The White Lotus," the character Victoria Ratliff takes the prescription anti-anxiety medication lorazepam to help with her social anxiety and inability to sleep. Her casual usage ...
Nov 14, 2025
0
14
GLP-1 and health: Beyond weight loss in the Ozempic era
This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these treatments for people ...
Nov 14, 2025
0
0
Family history key to predicting antidepressant response
A new study from Queen Mary University of London shows that a family's experience with certain medicines could help doctors predict how future generations will respond to the same drugs.
Nov 13, 2025
0
13
